Japan Panel to Review J-TEC’s Cell Product, Zolgensma on Feb. 26; Orphan Status for Luxturna Also Up for Discussion

February 20, 2020
The Ministry of Health, Labor and Welfare (MHLW) has officially announced a list of products to be reviewed by a key advisory panel for regenerative medicines, which revealed the approval of Japan Tissue Engineering’s (J-TEC) cell-based product EYE-01M is also...read more